TY - JOUR
T1 - Treatment of hypertension and dyslipidemia or their combination among US managed-care patients.
AU - Dutro, Michael P.
AU - Gerthoffer, Tracey D.
AU - Peterson, Eric D.
AU - Tang, Simon S.K.
AU - Goldberg, George A.
PY - 2007
Y1 - 2007
N2 - The authors examined treatment rates in managed-care patients with hypertension (HTN) only or dyslipidemia (DYS) only compared with patients who had both (HTN+DYS). A retrospective, cross-sectional claims analysis was performed in a 2002 US national managed-care database of 1.23 million continuously eligible members aged 18 years or older. Median age was 44.0 years, 8.8% were aged 65 years or older, and 53.2% were women. Study criteria identified 354,324 patients, 32.9% with HTN only, 34.7% with DYS only, and 32.4% with HTN+DYS. Overall, 49.7% of HTN patients had DYS and 48.3% of DYS patients had HTN. Patients with HTN+DYS were significantly older, more likely to have cardiovascular comorbidities, and more likely to use medications and hospital facilities than were patients with HTN only or DYS only (P<.01). About two-thirds of patients with HTN only received 1 or more prescription for an antihypertensive medication, compared with three-quarters of those with HTN+DYS. Fewer than half of patients with DYS only and approximately two-thirds with HTN+DYS received a cholesterol-lowering agent.
AB - The authors examined treatment rates in managed-care patients with hypertension (HTN) only or dyslipidemia (DYS) only compared with patients who had both (HTN+DYS). A retrospective, cross-sectional claims analysis was performed in a 2002 US national managed-care database of 1.23 million continuously eligible members aged 18 years or older. Median age was 44.0 years, 8.8% were aged 65 years or older, and 53.2% were women. Study criteria identified 354,324 patients, 32.9% with HTN only, 34.7% with DYS only, and 32.4% with HTN+DYS. Overall, 49.7% of HTN patients had DYS and 48.3% of DYS patients had HTN. Patients with HTN+DYS were significantly older, more likely to have cardiovascular comorbidities, and more likely to use medications and hospital facilities than were patients with HTN only or DYS only (P<.01). About two-thirds of patients with HTN only received 1 or more prescription for an antihypertensive medication, compared with three-quarters of those with HTN+DYS. Fewer than half of patients with DYS only and approximately two-thirds with HTN+DYS received a cholesterol-lowering agent.
UR - http://www.scopus.com/inward/record.url?scp=38449090424&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38449090424&partnerID=8YFLogxK
U2 - 10.1111/j.1524-6175.2007.07146.x
DO - 10.1111/j.1524-6175.2007.07146.x
M3 - Article
C2 - 17786069
AN - SCOPUS:38449090424
SN - 1524-6175
VL - 9
SP - 684
EP - 691
JO - Journal of clinical hypertension (Greenwich, Conn.)
JF - Journal of clinical hypertension (Greenwich, Conn.)
IS - 9
ER -